IQVIA IQV

HealthcareMarket cap $45B7 connections

IQVIA runs clinical trials for pharmaceutical companies (CRO services) and provides healthcare data and analytics through its massive database of 1B+ anonymized patient records from 100+ countries. Drug companies outsource Phase 1-3 trials to IQVIA because it's faster than running them internally. Its data business - selling anonymized prescription and patient data - has enormous pricing power.

Explore IQVIA on the interactive map Relationship timeline Find a path to another company

Customers 3

Companies IQVIA sells to

Eli LillyHealthcare · $700BDrug development data services
MerckHealthcare · $290BReal-world evidence analytics
PfizerHealthcare · $160BClinical trial management

Partners 6

Strategic partnerships, joint products and alliances

MicrosoftTechnology · $2.8TAzure clinical data
AmazonConsumer & Retail · $2.0TAWS life sciences
Johnson & JohnsonHealthcare · $380BClinical trial management
AbbVieHealthcare · $320BCommercial analytics
MerckHealthcare · $290BReal-world evidence studies
PfizerHealthcare · $160BDrug development analytics

Other Healthcare companies

Eli Lilly UnitedHealth Novo Nordisk Johnson & Johnson AbbVie Merck AstraZeneca Thermo Fisher Novartis Abbott Labs

Embed this on your site

Show IQVIA's network in an article or report - it updates as our data does.

<iframe src="https://vexmap.com/embed.html?co=IQV" width="600" height="420" style="border:0;border-radius:12px;max-width:100%" title="IQVIA on VexMap" loading="lazy"></iframe>

Preview

Relationships are compiled by VexMap from company filings, announcements and reporting, and last reviewed September 2026. Spotted something wrong? Tell us. Not investment advice.